IFNα activates dormant haematopoietic stem cells in vivo
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Maintenance of the blood system is dependent on dormant haematopoietic stem cells (HSCs) with long-term self-renewal capacity. After injury these cells are induced to proliferate to quickly re-establish homeostasis. The signalling molecules promoting the exit of HSCs out of the dormant stage remain largely unknown. Here we show that in response to treatment of mice with interferon-alpha (IFNalpha), HSCs efficiently exit G(0) and enter an active cell cycle. HSCs respond to IFNalpha treatment by the increased phosphorylation of STAT1 and PKB/Akt (also known as AKT1), the expression of IFNalpha target genes, and the upregulation of stem cell antigen-1 (Sca-1, also known as LY6A). HSCs lacking the IFNalpha/beta receptor (IFNAR), STAT1 (ref. 3) or Sca-1 (ref. 4) are insensitive to IFNalpha stimulation, demonstrating that STAT1 and Sca-1 mediate IFNalpha-induced HSC proliferation. Although dormant HSCs are resistant to the anti-proliferative chemotherapeutic agent 5-fluoro-uracil, HSCs pre-treated (primed) with IFNalpha and thus induced to proliferate are efficiently eliminated by 5-fluoro-uracil exposure in vivo. Conversely, HSCs chronically activated by IFNalpha are functionally compromised and are rapidly out-competed by non-activatable Ifnar(-/-) cells in competitive repopulation assays. Whereas chronic activation of the IFNalpha pathway in HSCs impairs their function, acute IFNalpha treatment promotes the proliferation of dormant HSCs in vivo. These data may help to clarify the so far unexplained clinical effects of IFNalpha on leukaemic cells, and raise the possibility for new applications of type I interferons to target cancer stem cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic pro-inflammatory signaling due to chronic infections or repetitive sterile inflammation, however, has been shown to be detrimental to HSPC self-renewal, promoting loss of quiescence and differentiation [61–65].”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [63]
In the citing paper
“The isolated effects of individual inflammatory cytokines, including type 1 interferons (IFNa/b) 1-3 , type 2 IFN (IFNg) 4-6 , TNFa 7,8 , and IL-1 9-11 , have been well-documented in mouse hematopoietic development.”
From Type 1 interferon perturbates clonal competition by reshaping human blood development (2026) · cites this paper as [9]
In the citing paper
“multiple different sterile and infection-associated inflammatory stimuli have been shown to provoke primitive hematopoietic stem cells (HSCs) to exit their long-term quiescent state and enter into active proliferation”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“The sterile inflammation that it promotes results in a temporarily discrete hematologic response consisting of transient peripheral blood (PB) cytopenias and a parallel increase in proliferation of long-term HSCs (LT-HSCs), all of which return to homeostatic levels within 4 days”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“In addition to IL-6, other cytokines such as IFNα, IFNγ, IL-1α, IL-1β, and TNFα can also directly activate HSCs (Baldridge et al., 2010; Essers et al., 2009; Pietras et al., 2014; Pietras et al., 2016; Sujer, 2014).”
From Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis (2018) · cites this paper as Essers et al., 2009
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Kiel, M. J., Yilmaz, Ö. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.05.026 · Cited by 3,168
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Wilson, A., Laurenti, E., Oser, G., van der Wath, R. C., Blanco-Bose, W., Jaworski, M., Offner, S., Dunant, C. F., Eshkind, L., Bockamp, E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.048 · Cited by 1,908
Self-citationInducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Bone-marrow haematopoietic-stem-cell niches
Wilson, A., & Trumpp, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1779 · Cited by 1,354
Self-citationHematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,242
Cited by
Items 901–1,000 of 1,002
Wang, H., Wu, Z., Liu, Y., Wang, M., Stalin, A., Guo, S., Li, J., Wu, C., Zhang, J., Tan, Y., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114852 · Cited by 12
Xu, T., Dai, J., Tang, L., Sun, L., Si, L., & Guo, J. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03502-7 · Cited by 13
HDAC6 deacetylates IDH1 to promote the homeostasis of hematopoietic stem and progenitor cells
Yang, J., Liu, Y., Yin, H., Xie, S., Zhang, L., Dong, X., Ni, H., Bu, W., Ma, H., Liu, P., et al. (2023) · EMBO Reports · doi:10.15252/embr.202256009 · Cited by 12
“IFN-a stimulates the quiescence of HSPCs and hence reduces the HSPC pool (Essers et al , 2009).”
Ahmad, M. H., Hegde, M., Wong, W. J., Mohammadhosseini, M., Garrett, L. J., Carrascoso, A., Issac, N. G., Ebert, B. L., Silva, J. C., Pihan, G. A., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010398 · Cited by 10
Roberts, A. L., Morea, A., Amar, A., West, M., Karrar, S., Lehane, R., Tombleson, P., Graham, D. S. C., Reynolds, J. A., Wong, C. C. Y., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2024-225585 · Cited by 10
Brennig, S., Rattmann, I., Lachmann, N., Schambach, A., Williams, D. A., & Moritz, T. (2012) · Cytotherapy · doi:10.3109/14653249.2011.646043 · Cited by 10
Melenhorst, J. J., & Barrett, A. J. (2010) · Cytotherapy · doi:10.3109/14653249.2010.530649 · Cited by 11
O’Neill, C., Siddiqi, I. N., Brynes, R. K., Vergara‐Lluri, M., Moschiano, E., & O'Connell, C. L. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2631-0 · Cited by 10
Gui, J., Zhao, B., Lyu, K., Tong, W., & Fuchs, S. Y. (2017) · Cancer Biology & Therapy · doi:10.1080/15384047.2017.1345395 · Cited by 10
Lakhan, R., & Rathinam, C. V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.622190 · Cited by 11
Myeloid cells promote interferon signaling-associated deterioration of the hematopoietic system
Feyen, J., Ping, Z., Chen, L., van Dijk, C., van Tienhoven, T. V. D., van Strien, P. M. H., Hoogenboezem, R. M., Wevers, M. J. W., Sanders, M. A., Touw, I. P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35318-x · Cited by 11
Sulzberger, L., Tan, E. M. S., Davis, P. F., Brasch, H. D., Tan, S. T., & Itinteang, T. (2018) · Frontiers in Surgery · doi:10.3389/fsurg.2018.00031 · Cited by 10
Myeloid Cells Restrict MCMV and Drive Stress-Induced Extramedullary Hematopoiesis through STAT1
Gawish, R., Bulat, T., Biaggio, M., Lassnig, C., Bagó-Horváth, Z., Macho‐Maschler, S., Poelzl, A., Simonović, N., Prchal‐Murphy, M., Rom, R., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.017 · Cited by 12
“…in the bone marrow by multiple mechanisms, including direct effects on hematopoietic stem cells (HSCs) and various hematopoietic progenitors (Baldridge et al., 2010; de Bruin et al., 2014; Ehninger et al., 2014; Essers et al., 2009; Haas et al., 2015; Hirche et al., 2017; Sato et al., 2009).”
BackgroundSelf-citationVarney, M. E., Boehm, D. T., DeRoos, K., Nowak, E. S., Wong, T. Y., Sen-Kilic, E., Bradford, S. D., Elkins, C. M., Epperly, M., Witt, W. T., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02376 · Cited by 10
In Vivo Pre-Instructed HSCs Robustly Execute Asymmetric Cell Divisions In Vitro
Girotra, M., Trachsel, V., Roch, A., & Lütolf, M. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218225 · Cited by 10
Juan, W. C., & Ong, S. T. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-396456-4.00007-9 · Cited by 13
Jak2V617F myeloproliferative neoplasm stem cells and interferon-alpha
Lane, S., & Mullally, A. (2013) · Oncotarget · doi:10.18632/oncotarget.986 · Cited by 10
How Cells Respond to Interferons
Pitini, V. V., Arrigo, C., & Altavilla, G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9603 · Cited by 10
Engelhard, S., Estruch, M., Qin, S., Engelhard, C. A., Rodríguez-González, F. G., Drilsvik, M., Gonzalez, J. M., Lu, J., Bryder, D., Nerlov, C., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114475 · Cited by 10
Liu, W., Zhang, X., Liu, J., Pu, L., Ai, L., Xu, H., Wang, G., Wang, D., Song, X., Zhang, Y., et al. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.03.010 · Cited by 10
Aberrant engagement of P-selectin drives hematopoietic stem cell aging in mice
Yang, D., Skinder, N., Kao, Y.-R., Chen, J., Thiruthuvanathan, V. J., Svendsen, A. F., Zhang, C., Dethmers-Ausema, B., Weersing, E., Maryanovich, M., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00880-8 · Cited by 11
“Functionally, inflammation can cause myeloid bias and reduced self-renewal of HSCs 43,58–63 , resembling the key HSC age-associated changes.”
Inflammatory signaling in the pathogenesis of acute myeloid leukemia
Baumann, A., & Ellegast, J. M. (2025) · HemaSphere · doi:10.1002/hem3.70188 · Cited by 10
“17,18 Aside from several alternative biological processes, which will not be in the spotlight of this review, a combination of genetic alterations and dysregulation of innate inflammatory signaling can drive malignant transformation.”
Chai, L., Li, C., Wang, X., Qin, Y., Sun, H., Du, J., Liu, Y., Hu, D., Xiong, J., Zhao, Z., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116336 · Cited by 10
Ringel, F., Kaeda, J., Schwarz, M., Oberender, C., Grille, P., Dörken, B., Marque, F., Manley, P. W., Radimerski, T., & le Coutre, P. (2014) · Acta Haematologica · doi:10.1159/000356784 · Cited by 9
Persistent Cutaneous Leishmania major Infection Promotes Infection-Adapted Myelopoiesis
Ferreira, F. L. B., Séguin, O., Descoteaux, A., & Heinonen, K. M. (2022) · Microorganisms · doi:10.3390/microorganisms10030535 · Cited by 9
Hematopoietic Stem Cells and Their Bone Marrow Niches
Pinho, S., & Zhao, M. L. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-7471-9_2 · Cited by 13
Pan, Y., Zuo, H., Wen, F., Huang, F., Zhu, Y., Cao, L., Sha, Q., Li, Y., Zhang, H., Shi, M., et al. (2022) · Leukemia · doi:10.1038/s41375-021-01499-5 · Cited by 10
Osaki, J., Yamazaki, S., Hikita, A., & Hoshi, K. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e08904 · Cited by 10
“HSCs in the bone marrow of mice treated with poly(I:C) are known to rapidly enter the cell cycle via direct IFN-I receptor (IFNAR) signaling and activation of signal transducer and activator of transcription 1 and AKT [32].”
BackgroundInterferons as the First Choice of Cytoreduction in Essential Thrombocythemia and Polycythemia Vera
How, J., & Hobbs, G. S. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.7026 · Cited by 9
Basal type I interferon signaling has only modest effects on neonatal and juvenile hematopoiesis
Li, Y., Yang, W., Wang, H. C., Patel, R. M., Casey, E. B., Denby, E., & Magee, J. A. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022008595 · Cited by 9
The CKS1/CKS2 Proteostasis Axis Is Crucial to Maintain Hematopoietic Stem Cell Function
Grey, W. E., Atkinson, S., Rix, B., Casado, P., Ariza‐McNaughton, L., Hawley, C., Sopoena, M. L., Bridge, K. S., Kent, D. G., Cutillas, P. R., et al. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000853 · Cited by 11
Rapid activation of hematopoietic stem cells
Thapa, R., Elfassy, E., Olender, L., Sharabi, O., & Gazit, R. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03377-6 · Cited by 9
“Immune activation by poly-Inosinic-poly-Cytidylic (pIpC), or by Lipopolysaccharide (LPS), are most useful for viral- or bacterial-like immune stimuli (Chavakis et al., 2019). pIpC stimulation activates type-I interferons and activates HSCs in the BM (Essers et al., 2009; Sato et al., 2009).”
BackgroundGupta, M. K., & Rath, P. C. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.01.005 · Cited by 9
Searles, S., Gauss, K. A., Wilkison, M., Hoyt, T., Dobrinen, E., & Meissner, N. N. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301344 · Cited by 9
Lu, X., Chen, Q., Rong, Y.-J., & Chen, J. (2016) · Scientific Reports · doi:10.1038/srep28082 · Cited by 9
“Several pathways for the effect of infections on HSPCs may include the following: (1) pro-inflammatory cytokines may signal to HSPCs; (2) pathogen-derived products may be sensed by HSPCs; and (3) changes in the niche may occur in response to infection6.”
BackgroundAn Immune-CNS Axis Activates Remote Hippocampal Stem Cells Following Spinal Transection Injury
Dehler, S., Lou, W. P.-K., Gao, L., Skabkin, M. A., Dällenbach, S., Neumann, A., & Martín-Villalba, A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00443 · Cited by 10
Sioud, M. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12957 · Cited by 9
Ruf, F., Schreck, C., Wagner, A., Grziwok, S., Pagel, C., Romero, S., Kieslinger, M., Shimono, A., Peschel, C., Götze, K. S. S., et al. (2016) · Stem Cells · doi:10.1002/stem.2416 · Cited by 9
Decoding Clonal Hematopoiesis: Emerging Themes and Novel Mechanistic Insights
Pendse, S., & Loeffler, D. (2024) · Cancers · doi:10.3390/cancers16152634 · Cited by 9
Takashima, K., Olszewska, M., Jethalia, V., Sirenko, M., Silverman, L. R., Tomalin, L. E., Carcamo, S., Hasson, D., & Papapetrou, E. P. (2025) · Blood · doi:10.1182/blood.2024025670 · Cited by 9
Is the bone marrow microenvironment the hidden catalyst in malignant haematopoiesis?
Mian, S. A., Ngo, S. D., & Bonnet, D. A. (2025) · Leukemia · doi:10.1038/s41375-025-02630-6 · Cited by 13
Inflammation perturbs hematopoiesis by remodeling specific compartments of the bone marrow niche
Swann, J. W., Zhang, R., Verovskaya, E. V., Calero‐Nieto, F. J., Wang, X., Proven, M. A., Hirakawa, H., Heubel, B. P., Shyu, P. T., Guo, X.-D. E., et al. (2025) · Blood · doi:10.1182/blood.2025029513 · Cited by 10
Bhowmik, S., Bose, A., & Sengupta, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1660709 · Cited by 9
“IFN-a has been shown to possess the ability to remove the dormancy of HSCs and activate them in vivo (45).”
Remodeling of the Bone Marrow Stromal Microenvironment During Pathogenic Infections
Mun, Y., Fazio, S., & Arrieta, C. N. (2021) · Current topics in microbiology and immunology · doi:10.1007/978-3-030-86016-5_3 · Cited by 15
Solimando, A. G., Melaccio, A., Vacca, A., & Ria, R. (2022) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2021.166 · Cited by 12
The impact of prenatal inflammation on hematopoietic development
Tseng, N. A., & Beaudin, A. E. (2023) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000770 · Cited by 8
“0000000000000770 Seminal findings over the last decade have demonstrated the ability of adult hematopoietic stem cells to respond directly to a wide range of inflammatory stimuli, including cytokines [1–5], TLR agonists [6,7], pathogen-associated molecular patterns (PAMPs) [8], and microbes [9].”
BackgroundResultGADD45A regulates subcutaneous fat deposition and lipid metabolism by interacting with Stat1
You, W., Liu, S., Li, J., Tu, Y., & Shan, T. (2023) · BMC Biology · doi:10.1186/s12915-023-01713-z · Cited by 9
Bermes, M., Rodriguez, M. J., Toledo, M. A. S., Ernst, S., Müller‐Newen, G., Brümmendorf, T. H., Chatain, N., Koschmieder, S., & Baumeister, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417560 · Cited by 8
“While IFN α is capable of inducing long-lasting deep molecular remission and promoting the cycling of dormant stem cells [25,26], the combination of IFN α with olaparib presents a potential synergistic drug combination worthy of further investigation.”
BackgroundHelminth induced monocytosis conveys protection from respiratory syncytial virus infection in mice
Burgess, M. O., Janas, P. P., Berry, K., Mayr, H., Mack, M., Jenkins, S. J., Bain, C. C., McSorley, H. J., & Schwarze, J. (2024) · Allergy · doi:10.1111/all.16206 · Cited by 9
In vivo divisional tracking of hematopoietic stem cells
Takizawa, H., & Manz, M. G. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06500.x · Cited by 10
Chronic myeloid leukemia stem cells and developing therapies
Donato, N. J., & Peterson, L. F. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.546921 · Cited by 8
“Several lines of evidence suggest that IFN-a modifies stem cell behavior [146].”
BackgroundLeber, B. F. (2011) · Current Oncology · doi:10.3747/co.v18i4.652 · Cited by 8
Dnmt3a-null hematopoietic stem and progenitor cells expand after busulfan treatment
Chen, J., Matatall, K. A., Feng, X., Hormaechea‐Agulla, D., Maharjan, M., Young, N. S., & King, K. Y. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.09.192 · Cited by 8
Toward Elucidating Epigenetic and Metabolic Regulation of Stem Cell Lineage Plasticity in Skin Aging
Lyu, Y., & Ge, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.903904 · Cited by 9
Duffy, F. J., Hertoghs, N., Du, Y., Neal, M. L., Oyong, D. A., McDermott, S. M., Minkah, N. K., Carnes, J., Schwedhelm, K. V., McElrath, M. J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1042741 · Cited by 10
“Also, it has been shown that type I interferon is involved in hematopoiesis (68, 69) and activates dormant hematopoietic stem cells.”
BackgroundCD150-dependent hematopoietic stem cell sensing of Brucella instructs myeloid commitment
Hysenaj, L., de Laval, B., Gorvel, V. A., Bosilkovski, M., González-Espinoza, G., Debroas, G., Sieweke, M. H., Sarrazin, S., & Gorvel, J. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20210567 · Cited by 9
Naka, K., Hoshii, T., Tadokoro, Y., & Hirao, A. (2011) · Pathology International · doi:10.1111/j.1440-1827.2011.02688.x · Cited by 10
Virus-associated activation of innate immunity induces rapid disruption of Peyer’s patches in mice
Heidegger, S. M., Anz, D., Stephan, N., Bohn, B., Herbst, T., Fendler, W. P., Suhartha, N., Sandholzer, N., Kobold, S., Hotz, C., et al. (2013) · Blood · doi:10.1182/blood-2013-01-479311 · Cited by 8
Signal, Transduction, and the Hematopoietic Stem Cell
Louria‐Hayon, I. (2014) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10167 · Cited by 10
Zhao, H., Xu, C., Lee, T., Liu, F., & Choi, K. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24483 · Cited by 8
“Similar to the 5-FU injury model, repeated poly I:C administration, which perturbs steady-state hematopoiesis (Sato et al., 2009; Essers et al., 2009), leads to seemingly rapid loss of hematopoietic stem cell number and their hematopoietic reconstitution potential in Mx1-Cre; Etv2f/f mice (Lee et…”
Ostrander, E. L., Koh, W. K., Mallaney, C., Kramer, A. C., Wilson, W. C., Zhang, B., & Challen, G. A. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.09.004 · Cited by 10
Hematopoietic Stem Cells in Health and Disease—Insights from Single-Cell Multi-omic Approaches
Haas, S. F. (2020) · Current Stem Cell Reports · doi:10.1007/s40778-020-00174-2 · Cited by 9
Inflammation rapidly recruits mammalian GMP and MDP from bone marrow into regional lymphatics
Serrano‐López, J., Hegde, S., Kumar, S., Serrano, J., Fang, J., Wellendorf, A. M., Roche, P. A., Rangel, Y., Carrington, L. J., Geiger, H., et al. (2021) · eLife · doi:10.7554/elife.66190 · Cited by 8
Clonal selection parallels between normal and cancer tissues
Salavaty, A., Azadian, E., Naik, S. H., & Currie, P. D. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.01.007 · Cited by 12
Olender, L., Bujanover, N., Sharabi, O., Goldstein, O., & Gazit, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-58724-x · Cited by 8
Polycythemia vera: the current status of preclinical models and therapeutic targets
Bartalucci, N., Guglielmelli, P., & Vannucchi, A. M. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1762176 · Cited by 8
“Taking into the account the ability of IFNa to induce HSC exhaustion [158,159] and molecular response in”
BackgroundLi, Z., Fu, X., Wu, W., Liu, Z., Chen, Z., Zhou, C., Liu, Y., Kuang, M., Sun, F., Xiao, F., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102039 · Cited by 9
Vicenzi, S., Gao, F., Côté, P., Hartman, J. D., Avsharian, L. C., Vora, A. A., Rowe, R. G., Li, H., Skowronska‐Krawczyk, D., & Crews, L. A. (2025) · GeroScience · doi:10.1007/s11357-025-01594-w · Cited by 7
Single-cell multiomics identifies Tcf1 and Lef1 as key initiators of early thymic progenitor fate
Zhao, X., Hu, S. S., Lee, W.-H., Zakrzewski, J. L., Mi, Q., Rosenstein, R. K., Zang, C., Ma, X., & Xue, H. (2025) · Science Immunology · doi:10.1126/sciimmunol.adq8970 · Cited by 9
Meaker, G. A., Nicholls, M., Chahrour, C., Hsu, I., Smith, A., Bozhilov, Y. K., Leung, M. G. H., Vassort, H., Olender, L., Beaven, O., et al. (2025) · Blood · doi:10.1182/blood.2025029115 · Cited by 9
Translating Molecular Insights into Effective Targeting of Glioblastoma Stem Cells
Singh, S., Kapkoti, D. S., & Singh, G. (2026) · Cancers · doi:10.3390/cancers18050860 · Cited by 8
Clinical Trials in Chronic Myeloid Leukemia
Saußele, S., & Pfirrmann, M. (2012) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-012-0118-1 · Cited by 7
Iida, R., Welner, R. S., Zhao, W., Alberola‐Ila, J., Medina, K. L., Zhao, Z. J., & Kincade, P. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093643 · Cited by 7
“Stem/progenitors that normally lack Sca-1 could have acquired it as a result of such cytokine influence [43,44].”
BackgroundRyk modulates the niche activity of mesenchymal stromal cells by fine-tuning canonical Wnt signaling
Jeong, S., Lyu, J., Kim, J., & Oh, I. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0477-y · Cited by 7
Recreating the Bone Marrow Microenvironment to Model Leukemic Stem Cell Quiescence
O’Reilly, E., Zeinabad, H. A., Nolan, C., Sefy, J., Williams, T. H., Tarunina, M., Hernandez, D., Choo, Y., & Szegezdi, É. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.662868 · Cited by 8
Schlafen2 is a regulator of quiescence in adult murine hematopoietic stem cells
Warsi, S., Dahl, M., Smith, E. M. K., Rydström, A., Mansell, E., Sigurðsson, V., Sjöberg, J., Soneji, S., Rörby, E., Siva, K., et al. (2022) · Haematologica · doi:10.3324/haematol.2021.279799 · Cited by 8
The research progress of targeted therapy in acute myeloid leukemia based on bibliometric analysis
Huang, W., Sun, G., Wang, Q., & Long, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.957370 · Cited by 8
“For example, combination drug treatments where the first treatment aims to activate quiescent LSCs or remove them from the quiescence driving niche, such as CXCR4 antagonists or E-selectin inhibitors that potentially block CD44 activation, combined with a cytotoxic drug, hold promise (63, 64).”
BackgroundYu, Y., Dou, S., Peng, P., Ma, L., Qi, X., Liu, T., Yu, Y., Wei, C., & Shi, W. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106615 · Cited by 7
Dissecting dormancy and quiescence in hematopoietic stem cells
Ibneeva, L., & Grinenko, T. (2024) · Frontiers in Hematology · doi:10.3389/frhem.2024.1401713 · Cited by 8
Efficient Generation of Plasmacytoid Dendritic Cell from Common Lymphoid Progenitors by Flt3 Ligand
Chen, Y., Chang, S., Chen, T., & Lee, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135217 · Cited by 8
Cycling toward Elimination of Leukemic Stem Cells
Goff, D. J., & Jamieson, C. H. M. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.03.008 · Cited by 7
“Interestingly, interferona treatment, which can activate quiescent HSCs (Essers et al., 2009) and may help to eradicate quiescent BCR-ABL-expressing HSCs in chronic myeloid leukemia, presents another line of evidence for the use of cell-cycle stimulation in treating LSCs.”
BackgroundInfluentialCancer stem cells: emerging actors in both basic and clinical cancer research
Karakaş, D., Cevatemre, B., & Ulukaya, E. (2014) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1406-93 · Cited by 12
“INFα, arsenic trioxide (As2O3) Induction of quiescent cells to proliferate Ito et al., 2008; Essers et al., 2009 All-trans retinoic acid (ATRA) Inhibition of ALDH activity Croker et al., 2012 Curcumin Inhibition of cell migration, invasion, and colony formation in vitro and tumor growth and liver…”
Beyond tyrosine kinase inhibitors: Combinations and other agents
Cayssials, É., & Guilhot, F. (2016) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2016.10.017 · Cited by 7
“Of interest the data recently observed in animal models showing the potential synergy between imatinib and IFN justified testing this hypothesis in humans [56,57].”
Malouf, C., & Ottersbach, K. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.07.004 · Cited by 7
“They can also increase the proliferation of adult hematopoietic stem and progenitor cells [13-15].”
BackgroundZhu, W., Li, L., & Li, D. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29470 · Cited by 7
“Moreover, a prolonged exposure of the cells to IFN can exhaust the pool of HSCs and impair their functions (Essers et al., 2009).”
BackgroundRetractedAnalyzing signaling activity and function in hematopoietic cells
Kull, T., & Schroeder, T. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201546 · Cited by 7
“For example, both IFN-γ and IFN-α activate quiescent hematopoietic stem cells (HSCs) and trigger cycling (Baldridge et al., 2010; Essers et al., 2009) and emergency megakaryopoiesis (Chicha et al.”
BackgroundAmbrosi, T. H., & Chan, C. K. F. (2021) · Current topics in microbiology and immunology · doi:10.1007/978-3-030-86016-5_1 · Cited by 9
“Similarly, persistent type 1 and 2 interferon signaling keeps HSPCs in an activated non-dormant state that favors myeloid-bias (Essers et al. 2009; Matatall et al. 2014).”
BackgroundPro-Inflammatory Phenotype Induced by Maternal Immune Stimulation During Pregnancy
Nicholas, M., Mandal, M., Elkabes, S., Zhang, P., Sadoshima, J., Basak, S., Zhai, P., & DONNELLY, R. J. (2013) · InTech eBooks · doi:10.5772/53990 · Cited by 9
“Addi‐ tionally, treatment of mice with TLR3 agonist poly(I:C) activates HSCs to proliferate [103].”
BackgroundLemieux, M. E., Cheng, Z., Zhou, Q., White, R., Cornell, J. E., Kung, A. L., & Rebel, V. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024153 · Cited by 8
“, were over-represented only in intronic targets. Also selectively enriched in intronic target promoters were binding sites for interferon-responsive factor 1 (IRF1) and the glucocorticoid receptor (NR3C1). Interferon alpha has been shown to trigger HSC cycling”
BackgroundWong, Y. F., Micklem, C. N., Taguchi, M., Itonaga, H., Sawayama, Y., Imanishi, D., Nishikawa, S., Miyazaki, Y., & Jakt, L. M. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0035 · Cited by 7
Striving to achieve safe, permanent treatment discontinuation in chronic myeloid leukemia
Mauro, M. J. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.07.029 · Cited by 7
Dourcy, M., Maquet, C., Dams, L., Gilliaux, G., Javaux, J., Desmecht, D. J.-M., Mack, M., Dewals, B. G., Machiels, B., & Gillet, L. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0293-7 · Cited by 7
Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases
Melikyan, A. L., Subortseva, I. N., Gilyazitdinova, E., Koloshejnova, T. I., Pustovaya, E. I., Ek, E., Kovrigina, A. M., Sudarikov, A. B., Абдуллаев, А. О., Галактионовна, Л. Е., et al. (2018) · Terapevticheskii arkhiv · doi:10.26442/terarkh201890723-29 · Cited by 7
Determinants, mechanisms, and functional outcomes of myeloid cell diversity in cancer
Caronni, N., Montaldo, E., Mezzanzanica, L., Cilenti, F., Genua, M., & Ostuni, R. (2021) · Immunological Reviews · doi:10.1111/imr.12944 · Cited by 6
Tomishima, S. A., Kim, D. D., Porter, N., Guha, I., Dar, A. A., Ortega-Burgos, Y., Roof, J., Fazelinia, H., Spruce, L. A., Thom, C. S., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci180913 · Cited by 7
Ashayeripanah, M., Roquilly, A., & Villadangos, J. A. (2026) · Immunological Reviews · doi:10.1111/imr.70087 · Cited by 7
Megakaryopoiesis impairment through acute innate immune signaling activation by azacitidine
Okoye-Okafor, U. C., Javarappa, K. K., Tsallos, D., Saad, J. J., Yang, D., Zhang, C., Benard, L., Thiruthuvanathan, V. J., Cole, S., Ruiz, S. B., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20212228 · Cited by 8
“Contrary to its inhibitory effects in Mk lineage-committed progenitor cells, IFN-I can activate quiescent stem cells and increase Mk lineage output (Essers et al., 2009; Haas et al., 2015).”
The role of the microbiota in myelopoiesis during homeostasis and inflammation
Kim, Y., & Kamada, N. (2023) · International Immunology · doi:10.1093/intimm/dxad002 · Cited by 9
Zaunz, S., Smedt, J. D., Lauwereins, L., Cleuren, L., Laffeber, C., Bajaj, M. S., Lebbink, J. H. G., Marteijn, J. A. F., Keersmaecker, K. D., & Verfaillie, C. M. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10550-0 · Cited by 6
BST2 facilitates activation of hematopoietic stem cells through ERK signaling
Florez, M. A., Thatavarty, A., Le, D. T., Hill, H. A., Jeong, Y., Ho, B. M., Kuś, P., Wathan, T. K., Kain, B. N., Huang, S., et al. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104653 · Cited by 6
Metadata
- Authors
- Essers, M. A. G., Offner, S., Blanco-Bose, W. E., Waibler, Z., Kalinke, U., Duchosal, M. A., & Trumpp, A.
- Affiliations
- German Cancer Research Center (DE)
- École Polytechnique Fédérale de Lausanne (CH)
- Paul Ehrlich Institut (DE)
- Center for Experimental and Clinical Infection Research (DE)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Trumpp, Andreas
- Venue
- Nature
- Published
- 2009-02-11
- Volume
- 458
- Issue
- 7240
- Pages
- 904-908
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2011059916
- Cited by
- 1,368
- References
- 31
- Citations by year
- 2026: 59 · 2025: 72 · 2024: 67 · 2023: 96 · 2022: 91 · 2021: 99 · 2020: 90 · 2019: 72 · 2018: 68 · 2017: 81 · 2016: 82 · 2015: 60 · 2014: 99 · 2013: 80 · 2012: 71
- FWCI
- 56.02
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- hematopoietic stem cells, interferon-alpha, HSC proliferation, STAT1, Sca-1, IFNAR, type I interferon, 5-fluorouracil, leukemia, cancer stem cells, chemosensitization
- MeSH terms
- Animals, Antigens, Ly, Cell Count, Cell Cycle, Fluorouracil, Hematopoietic Stem Cells, Membrane Proteins, Mice, Inbred C57BL, Phosphorylation, Signal Transduction, Up-Regulation, Interferon-alpha, Cell Proliferation, STAT1 Transcription Factor, Mice, Receptor, Interferon alpha-beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.